Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance.
- NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_assertion description "[G-CSF has also been applied in priming strategies designed to enhance the sensitivity of leukemia stem cells to cytotoxic agents, in protocols aimed to induce their differentiation and accompanying growth arrest and cell death, and in severe aplastic anemia and myelodysplastic syndrome (MDS) to alleviate anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance.
- NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_assertion evidence source_evidence_literature NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance.
- NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_assertion SIO_000772 20237318 NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance.
- NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_assertion wasDerivedFrom befree-2016 NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance.
- NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_assertion wasGeneratedBy ECO_0000203 NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance.
- befree-2016 importedOn "2016-02-19" NP800644.RA1u-FnQalFCCu-b4BZRs9jOmMxmXUJniffE_lt0s1GNY130_provenance.